BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CEBPA, CEBP, 1050, C/EBP-alpha, P49715
102 results:

  • 1. Cardiac glycoside neriifolin exerts anti-cancer activity in prostate cancer cells by attenuating DNA damage repair through endoplasmic reticulum stress.
    Zhao W; Li G; Zhang Q; Chen M; He L; Wu Z; Zhang Y; Fan M; Liang Y; Zhang W; Zeng F; Deng F
    Biochem Pharmacol; 2023 Mar; 209():115453. PubMed ID: 36792037
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Antioxidative, anti-inflammatory, and anticancer properties of the red biopigment extract from Monascus purpureus (MTCC 369).
    Chaudhary V; Katyal P; Panwar H; Kaur J; Aluko RE; Puniya AK; Poonia AK
    J Food Biochem; 2022 Sep; 46(9):e14249. PubMed ID: 35615960
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. prostate cancer awareness among transgender women after gender-affirming surgery.
    Pitak-Arnnop P; Messer-Peti R; Tangmanee C; Neff A; Meningaud JP
    Prostate; 2022 Jun; 82(10):1060-1067. PubMed ID: 35416318
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Antiandrogen enzalutamide induced genetic, cellular, and hepatic damages: amelioration by triterpene Lupeol.
    Khan MA; Singh D; Fatma H; Akhtar K; Arjmand F; Maurya S; Siddique HR
    Drug Chem Toxicol; 2023 Mar; 46(2):380-391. PubMed ID: 35188013
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design.
    Freedland SJ; De Giorgi U; Gleave M; Rosbrook B; Shen Q; Sugg J; Haas GP; Shore ND
    BMJ Open; 2021 Aug; 11(8):e046588. PubMed ID: 34385241
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An Optimal Surgical Plane for Laparoscopic Functional Total Mesorectal Excision in Rectal cancer.
    Li K; He X; Zheng Y
    J Gastrointest Surg; 2021 Oct; 25(10):2726-2727. PubMed ID: 34109532
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Taxanes Sensitize prostate cancer Cells to TRAIL-Induced Apoptotic Synergy via Endoplasmic Reticulum Stress.
    Grayson KA; Hope JM; Wang W; Reinhart-King CA; King MR
    Mol Cancer Ther; 2021 May; 20(5):833-845. PubMed ID: 33632873
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Treatment of Large Non-Muscle-Invasive Bladder cancer: The Potential Role of Neoadjuvant Intravesical Chemotherapy.
    Raber M; Buchholz N; Vercesi A; Hendawi NA; Inneo V; Di Paola G; Tessa L; Gazzano G; Viglio A; Hasan IM
    Urol Int; 2021; 105(3-4):298-303. PubMed ID: 33333529
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tribbles-1 Expression and Its Function to Control Inflammatory Cytokines, Including Interleukin-8 Levels are Regulated by miRNAs in Macrophages and prostate cancer Cells.
    Niespolo C; Johnston JM; Deshmukh SR; Satam S; Shologu Z; Villacanas O; Sudbery IM; Wilson HL; Kiss-Toth E
    Front Immunol; 2020; 11():574046. PubMed ID: 33329538
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identifying the relationship between postoperative urinary continence and residual urethra stump measurements in robot assisted radical prostatectomy patients.
    Beulens AJW; Brinkman WM; Umari P; Koldewijn EL; Hendrikx AJM; van Basten JP; van Merriënboer JJG; van der Poel HG; Bangma C; Wagner C
    Int J Med Robot; 2021 Apr; 17(2):e2196. PubMed ID: 33113236
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. prostate cancer Biomarker Development: National cancer Institute's Early Detection Research Network prostate cancer Collaborative Group Review.
    Liss MA; Leach RJ; Sanda MG; Semmes OJ
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2454-2462. PubMed ID: 33093161
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Epigenetics/Epigenomics and Prevention of Early Stages of cancer by Isothiocyanates.
    Hudlikar R; Wang L; Wu R; Li S; Peter R; Shannar A; Chou PJ; Liu X; Liu Z; Kuo HD; Kong AN
    Cancer Prev Res (Phila); 2021 Feb; 14(2):151-164. PubMed ID: 33055265
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Radiomics Improves cancer Screening and Early Detection.
    Gillies RJ; Schabath MB
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2556-2567. PubMed ID: 32917666
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Transient renal dysfunction due to rhabdomyolysis after robot-assisted radical prostatectomy.
    Onagi A; Haga N; Tanji R; Honda R; Matsuoka K; Hoshi S; Koguchi T; Hata J; Sato Y; Akaihata H; Kataoka M; Ogawa S; Kojima Y
    Int Urol Nephrol; 2020 Oct; 52(10):1877-1884. PubMed ID: 32451781
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Androgens and Overall Survival in Patients With Metastatic Castration-resistant prostate cancer Treated With Docetaxel.
    Ryan CJ; Dutta S; Kelly WK; Middleberg R; Russell C; Morris MJ; Taplin ME; Halabi S;
    Clin Genitourin Cancer; 2020 Jun; 18(3):222-229.e2. PubMed ID: 32273234
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Fish Lipid against prostate cancer (PC-3) through Apoptosis and Cell Cycle Arrest.
    Gupta P; Serajuddin M
    Nutr Cancer; 2021; 73(2):300-306. PubMed ID: 32242459
    [TBL] [Abstract] [Full Text] [Related]  

  • 17.
    Martínez-Rojo E; Cariño-Cortés R; Berumen LC; García-Alcocer G; Escobar-Cabrera J
    Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32102219
    [No Abstract]    [Full Text] [Related]  

  • 18. Family Study Designs Informed by Tumor Heterogeneity and Multi-cancer Pleiotropies: The Power of the Utah Population Database.
    Hanson HA; Leiser CL; Madsen MJ; Gardner J; Knight S; Cessna M; Sweeney C; Doherty JA; Smith KR; Bernard PS; Camp NJ
    Cancer Epidemiol Biomarkers Prev; 2020 Apr; 29(4):807-815. PubMed ID: 32098891
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Leveraging Digital Data to Inform and Improve Quality cancer Care.
    Hernandez-Boussard T; Blayney DW; Brooks JD
    Cancer Epidemiol Biomarkers Prev; 2020 Apr; 29(4):816-822. PubMed ID: 32066619
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cyclin D1 and PSA act as good prognostic and clinicopathological indicators for breast cancer.
    Holah NS; Hemida AS
    J Immunoassay Immunochem; 2020; 41(1):28-44. PubMed ID: 31631753
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.